Coronary Heart Disease (CHD) Circulatory System Coronary heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hospital arm: 1. In- and out-hospital patients who meet the inclusion criteria and who agree to participate in the trial. Within each hospital (both intervention and usual care) all consecutive new patients with medical diagnosis of Coronary Heart Disease (CHD) (see below), men and women under 80 years of age, will be identified: 1.1. Acute coronary syndromes, unstable angina, non Q wave Myocardial Infarction (MI), Q wave MIb 1.2. Stable angina pectoris 2. Partners of patients living in the same household 3. First degree blood relatives of patients with premature CHD Primary Care arm: 1. High risk individuals who meet the following inclusion criteria and who agree to participate in the trial. Men and women, 50 years of age or older, but less than 80 years, without history of coronary heart disease were identified in three categories as follows: 1.1. High multifactorial risk individuals: CVD risk more than or equal to 5% over ten years (now or projected to age 60 years), according to the HeartScore risk estimation system 1.2. Antihypertensive and/or lipid-lowering therapies initiated in the last year 1.3. New or known diabetes diagnosed in the last three years 2. Partners of high-risk individuals living in the same household
Exclusion criteria
Exclusion criteria: Hospital arm: 1. Aged 80 years of age or older 2. Severe heart failure 3. Impaired cognitive function 4. Severe physical disability Primary Care arm: 1. Under 50 and over 80 years of age 2. Mentally or physically incapable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospital arm: 1. Coronary patients: Proportions of patients achieving European and national lifestyle, risk factors and therapeutic targets for cardiovascular disease prevention: 1.1. Smoking habit (self reported, breath carbon monoxide (CO) 1.2. Diet/nutrition (self reported, food habit questionnaire, 24 hour recall with analysis) 1.3. Physical activity (self reported, step counter, incremental shuttle walk test, international physical activity questionnaire) 1.4. Overweight/obesity (Body Mass Index [BMI], waist circumference) 1.5. Diabetes (known/new, fasting and random plasma glucose, glycated haemoglobin (Hb A1c), Glucose Tolerance Test (GTT) 1.6. Blood pressure (automatic sphygmomanometer) 1.7. Total cholesterol, High-Density Lipoprotein (HDL) cholesterol, triglycerides, calculated Low-Density Lipoprotein (LDL) cholesterol) 1.8. Prophylactic drug therapies: nicotine replacement therapy, bupropion hydrochloride, antiobesity drugs, antiplatelets, beta-blockers, Angiotensin Converting Enzyme (ACE)-inhibitors, lipid-lowering drugs, anticoagulants, hypoglycaemic drugs 2. Partners and first-degree relatives of patients with premature coronary disease living in the same household: Proportions of partners and first degree relatives achieving European and national lifestyle, risk factors and therapeutic targets for cardiovascular disease prevention: 2.1. Smoking habit (self reported, breath CO) 2.2. Diet/nutrition (self reported, food habit questionnaire, 24 hour recall with analysis) 2.3. Physical activity (self reported, step counter, international physical activity questionnaire) 2.4. Overweight/obesity (BMI, waist circumference) 2.5. Diabetes (known/new, fasting and random plasma glucose, Hb A1c) 2.6. Blood pressur | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital arm: 1. Coronary patients: 1.1. Psychosocial, depression (Hospital Anxiety and Depression (HAD) scale), compliance (self reported), health beliefs (health beliefs questionnaire), emotional state (global mood scale), illness perception (illness perception questionnaire), functional limitation (SF 36 questions) 1.2. Return to work 1.3. Service use 1.4. Health economics (EuroQoL questionnaire) 1.5. Cardiovascular events (recurrent nonfatal coronary and cardiovascular events and cardiovascular/total mortality) 2. Partners and first-degree relatives of patients with premature coronary disease living in the same household: 2.1. Psychosocial, depression (Hospital Anxiety and Depression (HAD) scale), compliance (self reported), health beliefs (health beliefs questionnaire), emotional state (global mood scale), illness perception (illness perception questionnaire), functional limitation (SF 36 questions) 2.2. Service use 2.3. Health economics (EuroQoL questionnaire) 2.4. Cardiovascular events (recurrent nonfatal coronary and cardiovascular events and cardiovascular/total mortality) Primary Care: 1. High-risk individuals: 1.1. Psychosocial, depression (Hospital Anxiety and Depression (HAD) scale), health beliefs and views about heart disease (health beliefs questionnaire), risk perception (risk perception questionnaire), functional limitation (SF 36 questions) 1.2. Service use 1.3. Health economics (EuroQoL questionnaire) 1.4. Cardiovascular events (nonfatal coronary and cardiovascular events and cardiovascular/total mortality) 2. Partners of high-risk individuals living in the same household: 2.1. Psychosocial, depression (Hospital Anxiety and Depression (HAD) scale) | — |
Countries
Denmark, England, France, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom